KATAMARYN
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Nov 2025)
What this means for you
This application is over — abandoned 10 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98209131
- Mark type
- Stylized text
- Filed
- 04 Oct 2023
- Published for opposition
- 11 Feb 2025
- Abandoned
- 10 Nov 2025
- Attorney of record
- Camille M. Miller
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals, diseases, and clinical trials; providing medical and scientific research information
Owner
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
- Boston Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 10 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2025 — PUBLISHED FOR OPPOSITION
- 05 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Jan 2025 — ASSIGNED TO LIE
- 23 Dec 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 24 May 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 May 2024 — LETTER OF SUSPENSION E-MAILED
- 24 May 2024 — SUSPENSION LETTER WRITTEN
- 23 May 2024 — ASSIGNED TO EXAMINER